Amgen Inc. (NASDAQ:AMGN) is one of the 7 Most Profitable Value Stocks to Buy Right Now. Amgen Inc. (NASDAQ:AMGN) is one of ...

Major market indexes such as the S&P 500 declined in the first few months of the year, but have since rebounded significantly. In contrast, biotech giant Amgen (NASDAQ: AMGN) started the year strong, ...

The quarter saw Amgen lift its total revenue by 12% year over year to $9.6 billion, fueled by double-digit increases in the sales of key drugs. Net income not according to generally accepted ...

Amgen has performed decently but it’s best returns are still ahead.

AmgenAMGN stock dropped Wednesday despite a beat-and-raise second quarter as investors look ahead to the next readouts for the company's MariTide weight-loss shot. In the fourth quarter, Amgen expects ...

In the latest close session, Amgen (AMGN) was up +2.89% at $349.81. The stock's performance was ahead of the S&P 500's daily gain of 2.51%. On the other hand, the Dow registered a gain of 2.85%, and ...

Amgen (NASDAQ:AMGN) is set to release its earnings on Tuesday, August 5, 2025. Historically, Amgen's stock has shown a tendency to experience negative one-day returns following its earnings ...

Amgen Inc. (NASDAQ:AMGN) is one of the best pharma stocks to invest in now. Amgen Inc. (NASDAQ:AMGN) announced on March 28 that Repatha® lowered the risk of first major adverse cardiovascular events ...